Jefferies Starts Valeant Pharmaceuticals (VRX) at Buy
Tweet
Share
E-mailGet Alerts VRX Hot Sheet
Price: $23.40 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 19
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 19
Join SI Premium – FREE
Jefferies initiates coverage on Valeant Pharmaceuticals (NYSE: VRX) with a Buy rating and a price target of $153.00. (NOTE: Report was released before VRX/Pershing Square offer for Allergan)
For an analyst ratings summary and ratings history on Valeant Pharmaceuticals click here. For more ratings news on Valeant Pharmaceuticals click here.
Shares of Valeant Pharmaceuticals closed at $126.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Honeywell Aerospace Inc (HONA) at Hold
- Macquarie Starts Cambricon Technologies Corp (688256:CH) at Outperform
- Nomura/Instinet Resumes Toyota Motor (7203:JP) (TM) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Pershing Square Capital, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
